Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.00792 USD | -16.63% | -12.22% | -58.42% |
04-16 | AXIM Biotechnologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-15 | AXIM Biotechnologies, Inc. announced that it has received $0.814555 million in funding | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
2.31M | - | - | - | - | - | |
59.34B | - | |||||
40.24B | ||||||
39.88B | ||||||
28.55B | ||||||
27.26B |